Literature DB >> 34150062

The Wnt pathway regulator expression levels and their relationship to bone metabolism in thoracolumbar osteoporotic vertebral compression fracture patients.

Xuefeng Ma1,2, Xiaoqi Zhu3, Xu He2, Xiaobo Yi2, Anmin Jin1.   

Abstract

OBJECTIVE: To investigate of the Wnt pathway serum regulator expression levels and their relationship with bone metabolism (BM) in thoracolumbar osteoporotic vertebral compression fracture (OVCF) patients.
METHODS: In this study, 40 healthy controls (group A), 33 osteoporotic patients (group B), and 47 thoracolumbar OVCF patients (group C) were recruited as the study cohort during the same period. The Wnt pathway serum regulator levels, bone density, BM-related inflammatory cytokines, bone formation markers, and bone resorption markers were compared among the three groups, and the correlation between the Wnt pathway serum regulators and BM was analyzed.
RESULTS: The β-catenin levels, the BALP, the densities at the femoral neck and lumbar spine, and the PINP, IL-10, OPG and BGP in groups B and C were lower than they were in group A, and the above indices in group C were lower than they were in group B (P < 0.05). Groups B and C showed higher CDKK-1, RANKL, TRACP-5b, β-CTX, IL-2, IL-6, MMP-2, MMP-9, Leptin, and TNF-α levels than group A, and the above indicators in group C were higher than they were in group B (P < 0.05). A Pearson's correlation analysis showed that the MMP-2, MMP-9, RANKL, β-CTX, and TRACP-5b levels were negatively correlated with β-catenin (r < 0, P < 0.05) and were positively correlated with DKK-1 (r > 0, P < 0.05). The BGP, PINP, OPG, and BALP levels were positively correlated with β-catenin (r > 0, P < 0.05) and were negatively correlated with DKK-1 (r < 0, P < 0.05).
CONCLUSION: Patients with thoracolumbar OVCF have abnormal Wnt pathway serum regulator expression levels, low bone density, and abnormal BM, and the patients' Wnt/β-catenin and DKK-1 levels are closely related to BM, so they may be potential targets for the prevention and treatment of metabolic bone diseases. AJTR
Copyright © 2021.

Entities:  

Keywords:  Osteoporosis; Wnt pathway; bone metabolism; osteoporotic vertebral compression fracture

Year:  2021        PMID: 34150062      PMCID: PMC8205725     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  24 in total

1.  Association of serum Dkk-1 levels with β-catenin in patients with postmenopausal osteoporosis.

Authors:  Jun Tian; Xiao-Juan Xu; Lin Shen; Yan-Ping Yang; Rui Zhu; Bo Shuai; Xi-Wen Zhu; Cheng-Gang Li; Chen Ma; Lin Lv
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

Review 2.  The WNT system: background and its role in bone.

Authors:  U H Lerner; C Ohlsson
Journal:  J Intern Med       Date:  2015-06       Impact factor: 8.989

3.  Osteoporotic thoracolumbar compression fractures: long-term retrospective comparison between vertebroplasty and conservative treatment.

Authors:  Konstantinos Martikos; Tiziana Greggi; Cesare Faldini; Francesco Vommaro; Antonio Scarale
Journal:  Eur Spine J       Date:  2018-04-19       Impact factor: 3.134

Review 4.  Targeting WNT signaling in the treatment of osteoporosis.

Authors:  Roland Baron; Francesca Gori
Journal:  Curr Opin Pharmacol       Date:  2018-05-09       Impact factor: 5.547

Review 5.  Wnt signaling and osteoporosis.

Authors:  Stavros C Manolagas
Journal:  Maturitas       Date:  2014-04-24       Impact factor: 4.342

6.  Application of Cement-Injectable Cannulated Pedicle Screw in Treatment of Osteoporotic Thoracolumbar Vertebral Compression Fracture (AO Type A): A Retrospective Study of 28 Cases.

Authors:  Zhigang Rong; Fei Zhang; Jun Xiao; Zhengdong Wang; Fei Luo; Zehua Zhang; Jianzhong Xu; Fei Dai
Journal:  World Neurosurg       Date:  2018-08-25       Impact factor: 2.104

7.  Isopsoralen regulates PPAR‑γ/WNT to inhibit oxidative stress in osteoporosis.

Authors:  Jian Wang; Gang Wang; Li Gong; Guanwen Sun; Bin Shi; Huhe Bao; Yan Duan
Journal:  Mol Med Rep       Date:  2017-11-03       Impact factor: 2.952

8.  Bone mass is inversely proportional to Dkk1 levels in mice.

Authors:  Bryan T MacDonald; Danese M Joiner; Sivan M Oyserman; Parul Sharma; Steven A Goldstein; Xi He; Peter V Hauschka
Journal:  Bone       Date:  2007-06-05       Impact factor: 4.398

9.  Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: A potential multifaceted relationship between OPG/RANKL/TRAIL and Wnt inhibitors.

Authors:  Ali Taylan; Merih Birlik; Gokce Kenar; Burak Toprak; Barıs Gundogdu; Oguz Gurler; Burak Karakas; Barıs Akıncı; Ali R Sisman
Journal:  Mod Rheumatol       Date:  2018-09-25       Impact factor: 3.023

10.  Epigallocatechin‑3‑gallate protects against secondary osteoporosis in a mouse model via the Wnt/β‑catenin signaling pathway.

Authors:  Jiancheng Xi; Qinggui Li; Xiaobo Luo; Jinlong Li; Lixin Guo; Haibin Xue; Guangsen Wu
Journal:  Mol Med Rep       Date:  2018-09-03       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.